143 related articles for article (PubMed ID: 38454306)
1. Dysregulation of the renin-angiotensin system in vascular dementia.
Tayler HM; Skrobot OA; Baron DH; Kehoe PG; Miners JS
Brain Pathol; 2024 Mar; 34(4):e13251. PubMed ID: 38454306
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.
MacLachlan R; Kehoe PG; Miners JS
J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1775-1783. PubMed ID: 35396835
[TBL] [Abstract][Full Text] [Related]
4. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia.
Thomas T; Miners S; Love S
Brain; 2015 Apr; 138(Pt 4):1059-69. PubMed ID: 25688080
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.
Kehoe PG; Hibbs E; Palmer LE; Miners JS
J Alzheimers Dis; 2017; 58(1):203-214. PubMed ID: 28387670
[TBL] [Abstract][Full Text] [Related]
6. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
7. Altered Gene Expression Within the Renin-Angiotensin System in Normal Aging and Dementia.
Tayler HM; MacLachlan R; Güzel Ö; Fisher RA; Skrobot OA; Abulfadl MA; Kehoe PG; Miners JS
J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37813091
[TBL] [Abstract][Full Text] [Related]
8. Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer's disease pathology in mouse models of Alzheimer's disease.
MacLachlan R; Evans CE; Chai SY; Good MA; Kehoe PG; Miners JS
Aging Brain; 2023; 3():100062. PubMed ID: 36911263
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.
Miners JS; Palmer JC; Love S
Brain Pathol; 2016 Jul; 26(4):533-41. PubMed ID: 26452729
[TBL] [Abstract][Full Text] [Related]
10. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
Kehoe PG; Al Mulhim N; Zetterberg H; Blennow K; Miners JS
J Alzheimers Dis; 2019; 72(2):525-535. PubMed ID: 31594235
[TBL] [Abstract][Full Text] [Related]
12. Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.
Ribeiro VT; Cordeiro TME; Filha RDS; Perez LG; Caramelli P; Teixeira AL; de Souza LC; Simões E Silva AC
Front Neurosci; 2021; 15():636754. PubMed ID: 33897352
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
Barker R; Ashby EL; Wellington D; Barrow VM; Palmer JC; Kehoe PG; Esiri MM; Love S
Brain; 2014 May; 137(Pt 5):1524-32. PubMed ID: 24618270
[TBL] [Abstract][Full Text] [Related]
14. Vascular angiotensin-converting enzyme expression regulates local angiotensin II.
Müller DN; Bohlender J; Hilgers KF; Dragun D; Costerousse O; Ménard J; Luft FC
Hypertension; 1997 Jan; 29(1 Pt 1):98-104. PubMed ID: 9039087
[TBL] [Abstract][Full Text] [Related]
15. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.
Miyazaki M; Takai S
J Pharmacol Sci; 2006; 100(5):391-7. PubMed ID: 16799256
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice.
Chen LN; Yang XH; Nissen DH; Chen YY; Wang LJ; Wang JH; Gao JL; Zhang LY
Shock; 2013 Nov; 40(5):420-9. PubMed ID: 23903854
[TBL] [Abstract][Full Text] [Related]
17. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
18. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.
Ababei DC; Bild V; Macadan I; Vasincu A; Rusu RN; Blaj M; Stanciu GD; Lefter RM; Bild W
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765259
[TBL] [Abstract][Full Text] [Related]
20. Modified Levels of Renin Angiotensin Related Components in the Frontal Cortex and Hippocampus were Associated with Neuroinflammation and Lower Neuroprotective Effects of NGF During Acute Hepatic Encephalopathy in Mice.
Oliveira NK; de Brito Toscano EC; Silva Oliveira BD; Dias Lima LC; Simões E Silva AC; de Miranda AS; Teixeira AL; Rachid MA
Protein Pept Lett; 2022; 29(12):1042-1050. PubMed ID: 36028967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
